Variant Laboratories debuts on bourses; GMP looks favourable

Shares of Valiant Laboratories are slated to begin trading on the stock exchanges today. Additionally, Valiant Laboratories' share price GMP increased 14.29% before to its IPO. 29.76 times were subscribed to the IPO. Retail Individual Investors (RIIs) quota got subscribed by 16.06 times, Non-Institutional Investors (NIIs) quota received a 73.64-time subscription, and Qualified Institutional Buyers (QIBs) category obtained a 20.83-time subscription.

“The IPO was well-received by investors, with a subscription rate of 29.76 times. The current GMP is also favorable, indicating a listing premium of over 15%. Valiant Laboratories’ financial performance has been improving in recent years, and the company plans to expand further. The IPO valuation was also considered fair,” said Shivani Nyati, Head of Wealth, Swastika Investmart.

“However, there are some concerns as it is a single-product manufacturing company. Secondly, it is dependent on a limited number of suppliers as well as customers. Also, there is intense competition in this industry. Investors might get a good listing benefit tomorrow, but they should also be cautious about related risks,” Shivani Nyati added.